NTRA - Natera, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$364.40
DETAILS
HIGH:
$475.00
LOW:
$245.00
MEDIAN:
$350.00
CONSENSUS:
$364.40
DOWNSIDE:
7.38%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Druckenmiller | 3,186,306 | $864.9M | 16.6% | +122,700 | INCREASED |
| Cooperman | 1,279,255 | $347.3M | 0.2% | +787,919 | INCREASED |
| Halvorsen | 390,694 | $106.1M | 0.3% | +390,694 | NEW |
| Greenblatt | 102,398 | $27.8M | 0.1% | +9,266 | INCREASED |
| Wood | 100,000 | $27.1M | 0.0% | -344,199 | DECREASED |
| Dalio | 6,136 | $1.7M | 0.0% | -19,101 | DECREASED |
| Laffont | 0 | $0 | -- | -- | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-10-15 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | M-Exempt | 50,000 | $10.41 | $520K |
| 2026-10-15 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | SELL | 286 | $388.32 | $111K |
| 2026-10-15 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | SELL | 714 | $389.84 | $278K |
| 2026-10-15 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | SELL | 300 | $394.39 | $118K |
| 2026-10-15 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | SELL | 800 | $393.47 | $315K |
| 2026-10-15 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | SELL | 1,900 | $396.30 | $753K |
| 2026-10-15 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | SELL | 1,100 | $397.16 | $437K |
| 2026-10-15 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | SELL | 600 | $398.09 | $239K |
| 2026-10-15 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | SELL | 793 | $399.31 | $317K |
| 2026-10-15 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | SELL | 2,671 | $400.31 | $1.1M |
| 2026-10-15 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | SELL | 5,974 | $401.42 | $2.4M |
| 2026-10-15 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | SELL | 6,309 | $402.23 | $2.5M |
| 2026-10-15 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | SELL | 3,858 | $403.27 | $1.6M |
| 2026-10-15 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | SELL | 10,321 | $404.64 | $4.2M |
| 2026-10-15 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | SELL | 6,274 | $405.18 | $2.5M |
| 2026-10-15 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | SELL | 1,400 | $406.63 | $569K |
| 2026-10-15 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | SELL | 3,800 | $407.27 | $1.5M |
| 2026-10-15 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | SELL | 2,000 | $408.24 | $816K |
| 2026-10-07 | Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | G-Gift | 6,000 | -- | -- |
| 2026-10-01 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | SELL | 954 | $413.11 | $394K |
| 2026-10-01 | Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | SELL | 1,273 | $413.31 | $526K |
| 2026-10-01 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1,846 | $415.07 | $766K |
| 2026-10-01 | Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | SELL | 200 | $411.62 | $82K |
| 2026-09-23 | Sheena Jonathan | director, other: CO-FOUNDER | SELL | 2,175 | $386.71 | $841K |
| 2026-09-23 | Sheena Jonathan | director, other: CO-FOUNDER | SELL | 390 | $385.29 | $150K |